TrialPloS one2012

Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

Shailender Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.